查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1655462

植入式藥物傳輸裝置的全球市場

Implantable Drug Delivery Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，美國植入式藥物輸送裝置的全球市場規模預計將達到 412 億美元

2024 年全球植入式藥物輸送裝置市場規模估計為 289 億美元，預計到 2030 年將達到 412 億美元，2024 年至 2030 年的複合年成長率為 6.1%。避孕植入是報告中分析的細分市場，預計其複合年成長率為 6.3%，在分析期結束時價值將達到 98 億美元。在分析期內，脊椎移植部分預計將以 5.7% 的複合年成長率成長。

美國市場規模估計為 80 億美元，中國市場預估年複合成長率為 5.7%

預計 2024 年美國植入式藥物輸送裝置市場規模將達 80 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 64 億美元，2024-2030 年分析期間的複合年成長率為 5.7%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 5.8% 和 4.9%。在歐洲，德國的複合年成長率預計為 5.1%。

全球植入式藥物傳輸設備市場 - 主要趨勢與促進因素摘要

什麼是可植入藥物輸送裝置？

植入式藥物輸送裝置是專門設計用於將藥物定向、控制和長期釋放到身體特定部位的醫療植入。這些設備將透過提供一致、精確的治療方法來改變醫療保健，特別是針對癌症、糖尿病和心血管疾病等慢性病。與吸收率可變的口服藥物或注射藥物不同，植入式裝置可確保持續給藥，從而提高治療效果並減少副作用。透過繞過消化器官系統並將藥物直接輸送到目標組織，這些設備為複雜的醫療狀況提供了更有效的解決方案，尤其對腫瘤學和內分泌學有益，因為精確的劑量至關重要。

科技進步如何影響植入式藥物傳輸市場？

生物材料、微電子和生物技術的進步顯著提高了植入式藥物傳輸裝置的功能性、耐用性和安全性。現代設備現在由生物相容性材料製成，這些材料在體內不太可能劣化，從而確保了長期有效性並減少了頻繁更換的需要。無線控制和微泵技術等創新技術可以實現可程式設計、可調節的藥物釋放，使醫療保健提供者能夠根據患者病情的變化調整劑量。此外，現在一些設備採用了感測器和連接技術，可以即時監測藥物輸送，從而及時調整並改善患者的治療效果。這些技術突破正在拓寬植入式裝置的範圍，使其能夠適應治療各種複雜的健康狀況。

為什麼植入式藥物輸送裝置變得越來越普遍？

慢性病、文明病的增加以及人口老化帶來了對更有效、更少侵入性治療方法的需求，使得植入式藥物輸送裝置在現代醫療保健中變得更加普遍。患者和醫療保健提供者越來越被這些設備的便利性和可靠性所吸引，這些設備消除了頻繁就診的需要，並提高了患者對規定方案的遵守率。此外，微創手術技術的進步使得植入過程更快、更少痛苦，進一步支持了其廣泛應用。這種長期持續用藥的措施反映了醫療保健領域的更大趨勢，即注重改善患者的生活品質，同時確保有效的疾病管理。

植入式藥物輸送裝置市場的成長受到多種因素的推動

植入式藥物輸送設備市場的成長受到多種因素的推動，包括技術的快速進步、慢性病盛行率的上升以及對個人化醫療的日益關注。生物材料和小型化技術的創新正在推動耐用、小型化設備的開發，這些設備可提供可靠、可控的藥物釋放，擴大其在癌症、荷爾蒙失調和神經系統疾病等疾病中的應用。對標靶治療和提高藥物生物有效性的需求不斷成長，刺激了這些設備的採用，特別是隨著醫療保健向以患者為中心的精準醫療的轉變。此外，新興市場醫療基礎設施的擴張和全球醫療支出的增加為採用這些先進設備創造了更多機會，進一步推動了市場成長。

部分

應用（避孕、眼科、心血管、糖尿病、腫瘤、自體免疫疾病、其他應用）、產品類型（避孕植入、脊椎移植、近距離放射治療種子、藥物釋放型支架、生物可吸收支架、眼內植入、輸液泵、其他產品類型）、技術（擴散、滲透、磁性、其他技術）、類型（生物分解性、非生物分解）

受訪企業範例（共46家）

  • Abbott Laboratories
  • Allergan PLC
  • Bausch and Lomb, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Medtronic PLC
  • Merck & Co., Inc.
  • Teleflex, Inc.
  • Varian Medical Systems, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP16492

Global Implantable Drug Delivery Devices Market to Reach US$41.2 Billion by 2030

The global market for Implantable Drug Delivery Devices estimated at US$28.9 Billion in the year 2024, is expected to reach US$41.2 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Spinal Implants segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.0 Billion While China is Forecast to Grow at 5.7% CAGR

The Implantable Drug Delivery Devices market in the U.S. is estimated at US$8.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Implantable Drug Delivery Devices Market - Key Trends & Drivers Summarized

What Are Implantable Drug Delivery Devices and Why Are They Transformative in Medicine?

Implantable drug delivery devices are specialized medical implants designed to provide targeted, controlled, and long-term drug release directly to specific areas within the body. These devices represent a transformative advancement in medicine, enabling treatment regimens that are both consistent and precise, particularly for chronic conditions like cancer, diabetes, and cardiovascular diseases. Unlike oral or injectable medications, which can vary in absorption rates, implantable devices ensure consistent drug dosing, improving treatment efficacy and reducing side effects. By bypassing the digestive system and delivering medication directly to target tissues, these devices offer a more effective solution for complex medical conditions, which is especially beneficial in oncology and endocrinology, where precise dosing is critical.

How Are Technological Advancements Shaping the Implantable Drug Delivery Market?

Advancements in biomaterials, microelectronics, and biotechnology have significantly enhanced the functionality, durability, and safety of implantable drug delivery devices. Modern devices are now made from biocompatible materials that resist degradation in the body, ensuring long-term efficacy and reducing the need for frequent replacements. Innovations such as wireless control and micro-pump technologies allow for programmable and adjustable drug release, enabling healthcare providers to tailor dosages based on a patient's evolving condition. Furthermore, some devices now incorporate sensors and connectivity features that enable real-time monitoring of drug delivery, allowing for timely adjustments and better patient outcomes. These technological breakthroughs are broadening the scope of implantable devices, making them highly adaptable for treating a range of complex health conditions.

Why Are Implantable Drug Delivery Devices Becoming More Commonplace?

The increasing prevalence of chronic and lifestyle-related diseases, along with a growing aging population, has driven demand for more efficient, less invasive treatment options, making implantable drug delivery devices more commonplace in modern healthcare. Patients and healthcare providers are increasingly drawn to the convenience and reliability of these devices, which eliminate the need for frequent hospital visits and enhance patient adherence to prescribed regimens. Additionally, advances in minimally invasive surgical techniques have made the implantation process quicker and less painful, further encouraging adoption. This shift toward long-term, continuous medication delivery reflects a larger trend in healthcare focused on improving patient quality of life while ensuring effective disease management.

The Growth in the Implantable Drug Delivery Devices Market Is Driven by Several Factors

The growth in the implantable drug delivery devices market is driven by several factors, including rapid technological advancements, rising prevalence of chronic diseases, and an increased focus on personalized medicine. Innovations in biomaterials and miniaturization technologies have allowed for the development of durable, compact devices that provide reliable, controlled drug release, expanding the application of these devices to conditions like cancer, hormonal imbalances, and neurological disorders. Growing demand for targeted therapies and improved drug bioavailability has fueled the adoption of these devices, particularly as healthcare shifts toward patient-centered, precision treatment. Additionally, the expansion of healthcare infrastructure in emerging markets and increased healthcare spending globally are creating more opportunities for the adoption of these advanced devices, further supporting market growth.

SCOPE OF STUDY:

The report analyzes the Implantable Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Other Applications); Product Type (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps, Other Product Types); Technology (Diffusion, Osmotic, Magnetic, Other Technologies); Type (Biodegradable, Non-biodegradable)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Allergan PLC
  • Bausch and Lomb, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Medtronic PLC
  • Merck & Co., Inc.
  • Teleflex, Inc.
  • Varian Medical Systems, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Implantable Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Targeted and Controlled Drug Release Mechanisms
    • Increased Adoption in Chronic Disease and Pain Management
    • Rising Focus on Biocompatible and Biodegradable Implantable Devices
    • Advancements in Micro- and Nano-technology for Precision Drug Delivery
    • Expansion of Implantable Drug Delivery in Oncology Treatments
    • Growth in Demand for Long-acting Implantable Devices in Diabetes Management
    • Surge in Use of Implantable Systems for Hormone Replacement Therapy
    • Demand for Minimally Invasive Implantable Drug Delivery Procedures
    • Integration of Smart Sensors for Real-time Drug Release Monitoring
    • Enhanced Patient Compliance with Sustained Release Drug Implants
    • Development of Refillable and Reusable Implantable Devices
    • Increasing Applications of Implantable Devices in Neurological Treatments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Implantable Drug Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Implantable Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Implantable Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spinal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Spinal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Spinal Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Brachytherapy Seeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Brachytherapy Seeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Brachytherapy Seeds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Bio-absorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Bio-absorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Bio-absorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Intraocular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Intraocular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Intraocular Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Non-biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Non-biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Non-biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Diffusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Osmotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Osmotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Osmotic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Magnetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Magnetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Magnetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Contraception by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Contraception by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Contraception by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 62: World Recent Past, Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 65: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 68: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: USA 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 71: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: USA 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 74: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: USA Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: USA 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: USA Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: USA 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 86: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Canada Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Canada Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 98: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Japan Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Japan Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 104: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: China 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: China 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: China 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: China Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: China 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Implantable Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 131: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: France 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: France 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: France 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 140: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: France 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Germany Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Italy Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 167: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: UK Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: UK 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 170: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: UK 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 173: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: UK Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: UK 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 176: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: UK Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: UK 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 203: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of World Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of World Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of World Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of World Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION